The PAN Foundation opens new small cell lung cancer patient assistance fund
The PAN Foundation today opened a new patient assistance program for people living with small cell lung cancer. Small cell lung cancer, also known as oat cell cancer, is a type of cancer that begins in the lungs and affects the respiratory system.
The American Cancer Society estimates that about 70 percent of people with small cell lung cancer will have metastatic cancer by the time they are diagnosed. Lung cancer is the leading cause of cancer death in men and women.
“Most people who are diagnosed with lung cancer are over the age of 65, and a significant majority will have metastatic cancer by the time they are diagnosed,” said PAN President and CEO Dan Klein. “Those affected by the illness are facing a serious diagnosis along with serious out-of-pocket costs. We’re thankful that because of our generous supporters, we are able to offer this essential financial assistance.”
Patients who qualify are eligible to receive $9,400 per year in financial assistance to pay for the deductibles, co-pays, and coinsurance costs associated with their treatment for small cell lung cancer.
To get financial assistance for small cell lung cancer, patients must:
- Be getting treatment for small cell lung cancer.
- Have Medicare health insurance that covers the qualifying medication or product.
- Have an income that falls at or below 400% of the Federal Poverty Level.
How to apply
Patients, caregivers or advocates applying on their behalf can apply for assistance using the PAN Foundation’s online patient portal.
About the PAN Foundation
The PAN Foundation is an independent, nationwide 501(c)(3) organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided more than $3 billion in financial assistance to nearly 1 million patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.
Liz Eckert, Director of Marketing and Communications
Was this helpful?